Cargando…

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus

Mostrar otras versiones (1)

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Min Kyong, Hur, Kyu-Yeon, Ko, Seung-Hyun, Park, Seok-O, Lee, Byung-Wan, Kim, Jin Hwa, Rhee, Sang Youl, Kim, Hyun Jin, Choi, Kyung Mook, Kim, Nan-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663674/ https://www.ncbi.nlm.nih.gov/pubmed/29086533 http://dx.doi.org/10.4093/dmj.2017.41.5.357

Ejemplares similares

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017)

2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
por: Kim, Mee Kyoung, et al.
Publicado: (2019)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
por: Moon, Jun Sung, et al.
Publicado: (2021)

2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
por: Hur, Kyu Yeon, et al.
Publicado: (2021)

Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2023)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
por: Kim, Hae Jin, et al.
Publicado: (2022)

2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
por: Choi, Jong Han, et al.
Publicado: (2023)

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
por: Kim, Gyuri, et al.
Publicado: (2016)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Hypoglycemic and hypolipidemic effects of Saururus chinensis Baill in streptozotocin-induced diabetic rats
por: Hwang, Ji-Yeon, et al.
Publicado: (2007)

Hypoglycemic effects of vanadium on alloxan monohydrate induced diabetic dogs
por: Kim, Joo-Min, et al.
Publicado: (2006)

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
por: Baek, Jong Ha, et al.
Publicado: (2022)

Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus
por: Kang, Min-Jung, et al.
Publicado: (2010)

Hypoglycemic effects of aqueous persimmon leaf extract in a murine model of diabetes
por: BAE, UI-JIN, et al.
Publicado: (2015)

Hypoglycemic and antioxidant effects of Daraesoon (Actinidia arguta shoot) in animal models of diabetes mellitus
por: Lee, Ah-Yeon, et al.
Publicado: (2015)

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
por: Noh, Junghyun, et al.
Publicado: (2023)

The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus
por: Kim, Hae Jin, et al.
Publicado: (2019)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
por: Moon, Jun Sung, et al.
Publicado: (2022)

Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Jung, Choungwon, et al.
Publicado: (2023)

Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
por: Bashir, Mir Iftikhar, et al.
Publicado: (2012)

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Khayyat, Yara A, et al.
Publicado: (2022)

Impaired Cortisol and Growth Hormone Counterregulatory Responses among Severe Hypoglycemic Patients with Type 2 Diabetes Mellitus
por: Rhyu, Young A, et al.
Publicado: (2019)

Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study
por: Kim, Yon Su, et al.
Publicado: (2019)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020
por: Ko, Seung-Hyun, et al.
Publicado: (2023)

Successful Treatment of Xanthoma Disseminatum with Combined Lipid Lowering Agents
por: Kim, Won-Jeong, et al.
Publicado: (2012)

Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013
por: Kim, Kyeong Jin, et al.
Publicado: (2018)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Meta-analysis of the association between new hypoglycemic agents and digestive diseases
por: Wang, Yu-Wen, et al.
Publicado: (2022)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i5jnd6vjk5kie8u5ju8bil9nf1